Trials / Conditions / Central Nervous System Tumor, Pediatric

Central Nervous System Tumor, Pediatric

10 registered clinical trials studyying Central Nervous System Tumor, Pediatric — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China NCT05672043	Beijing Tiantan Hospital	—
Completed	EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS NCT03638167	Seattle Children's Hospital	Phase 1
Active Not Recruiting	HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumor NCT03500991	Seattle Children's Hospital	Phase 1
Unknown	The Use of 5-aminolevulinic Acid (ALA) as an Intraoperative Tumor Marker for Resection of Pediatric Central Ne NCT02050243	Tel-Aviv Sourasky Medical Center	Phase 1 / Phase 2
Completed	Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy NCT01346267	University of South Florida	N/A
Terminated	Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer The NCT01348607	University of South Florida	Phase 2
Completed	Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer NCT00357500	Dana-Farber Cancer Institute	Phase 2
Completed	Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT NCT00084838	Dana-Farber Cancer Institute	Phase 2
Completed	Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma NCT00098865	Dana-Farber Cancer Institute	Phase 2
Terminated	Genetic Study of Brain Tumors in Young Children NCT00010101	Pediatric Brain Tumor Consortium	—